HIV pre-exposure prophylaxis re-initiation among men who have sex with men: a multi-center cohort study in China
Background Data on persistent use of HIV pre-exposure prophylaxis (PrEP) is limited among Chinese men who have sex with men (MSM). This study aimed to explore factors associated with the re-initiation of PrEP among Chinese MSM from a longitudinal PrEP demonstration trial. Methods A multi-center cohort study was conducted in Guangzhou and Wuhan, China (September 2021-2024), providing 1134 MSM participants with a 12-month dosage of tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) as oral PrEP. Following the trial, a subgroup of participants were invited to complete a 3-month post-trial follow-up survey. These participants were categorized on the basis of self-reported PrEP use patterns into (1) continued PrEP use, (2) discontinued without re-initiation, and (3) re-initiated after discontinuation. Log-binomial regression models were used to assess factors associated with PrEP re-initiation. Results Out of 408 participants who completed the 3-month post-trial follow-up survey, 70.1% (n =286/408) reported discontinuing PrEP, and 50.7% (n =145/286) of those who discontinued subsequently re-initiated PrEP. Participants who had concurrent sexual partnerships (adjusted risk ratio [aRR]=1.47, 95% CI: 1.11-1.96), used drugs during sex (aRR=1.34, 95% CI: 1.09-1.65), or lived alone (aRR=1.29, 95% CI: 1.03-1.61) were more likely to re-initiate PrEP. The Likert scale analysis indicated that perceived partner influence, specifically the expectation of condomless sex, played a significant role in re-initiation decisions (P =0.03). Conclusion Individuals engaging in higher-risk behaviors are more likely to re-initiate PrEP, highlighting the dynamic nature of risk perception. Future interventions should focus on promoting both re-initiation and consistent condom use, emphasizing partner-related dynamics and substance use as key factors in PrEP decisions among MSM.
Authors
- Linghua Li (ORCID: https://orcid.org/0000-0001-5711-8681)
- Quanmin Li (ORCID: https://orcid.org/0000-0001-8310-8823)
- Haojie Huang (ORCID: https://orcid.org/0000-0003-2751-6413)
- Jonathan Lio (ORCID: https://orcid.org/0000-0002-3723-2767)
- Zhuoheng Yin (ORCID: https://orcid.org/0009-0006-7012-5986)
- Renslow D. Sherer (ORCID: https://orcid.org/0000-0003-3780-2675)
- Weiming Tang (ORCID: https://orcid.org/0000-0002-9026-707X)
- Heping Zhao (ORCID: https://orcid.org/0000-0002-7746-575X)
- Aniruddha Hazra (ORCID: https://orcid.org/0000-0001-8557-4465)
- Joseph D. Tucker (ORCID: https://orcid.org/0000-0003-2804-1181)
- Chunyan Li (ORCID: https://orcid.org/0000-0001-9388-1799)
- Cheng Wang (ORCID: https://orcid.org/0000-0002-8337-167X)
- Ke Liang (ORCID: https://orcid.org/0000-0003-0490-5328)
- Chengxin Fan
- Songjie Wu
- Yifan Dai
Institutions
- University of London (GB)
- Wuhan University (CN)
- University of Chicago (US)
- Third Affiliated Hospital of Southern Medical University (CN)
- London School of Hygiene & Tropical Medicine (GB)
- University of Tokyo Hospital (JP)
- Zhongnan Hospital of Wuhan University (CN)
- Peng Cheng Laboratory (CN)
- United Continental (United States) (US)
- Guangzhou Eighth People's Hospital (CN)
- Tongji Hospital (CN)
- Southern Medical University (CN)
- The University of Tokyo (JP)
- Nanjing Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Sexual Health
- Published
- 2025-03-16
- DOI
- https://doi.org/10.1071/sh24200
- Citations
- 2
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Gilead Sciences
- University of Washington